125163-12-4

Basic information

• Product Name: 4-Fluoro-5-methoxy-2-nitroaniline
• Synonyms: 4-Fluoro-5-methoxy-2-nitroaniline;BenzenaMine, 4-fluoro-5-Methoxy-2-nitro-;4-Fluoro-5-methoxy-2-nitro-phenylamine
• CAS NO: 125163-12-4
• Molecular Formula: C₇H₇FN₂O₃
• Molecular Weight: 186.1404832
• Mol File: 125163-12-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Fluoro-5-methoxy-2-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Fluoro-5-methoxy-2-nitroaniline(125163-12-4)
• EPA Substance Registry System: 4-Fluoro-5-methoxy-2-nitroaniline(125163-12-4)

Safety Data

• Hazardous Substances Data: 125163-12-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-Fluoro-5-methoxy-2-nitroaniline is used as a key intermediate in organic synthesis for the production of a variety of complex organic compounds. Its unique combination of functional groups facilitates multiple reaction pathways, making it a versatile building block in the synthesis of specialty chemicals.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 4-Fluoro-5-methoxy-2-nitroaniline serves as a crucial precursor in the synthesis of certain drugs. Its presence in the molecular structure can impart specific therapeutic properties, contributing to the development of new medications with targeted effects.
Used in Agrochemicals:
4-Fluoro-5-methoxy-2-nitroaniline is also utilized in the agrochemical sector, where it is employed as a starting material for the synthesis of various pesticides and other agricultural chemicals. Its role in these applications is to provide the necessary chemical structure for effective pest control and crop protection.
Used in Materials Science:
4-Fluoro-5-methoxy-2-nitroaniline has been studied for its potential use in materials science, where it may contribute to the development of new materials with specific properties. Its unique structure could be leveraged to create materials with tailored characteristics for use in various applications.
Safety Considerations:
It is important to handle 4-Fluoro-5-methoxy-2-nitroaniline with care, as it can be harmful if ingested or inhaled and may cause irritation to the skin and eyes. Proper safety measures should be taken during its use to minimize potential health risks.

Upstream product

• 78056-39-0 4,5-difluoro-2-nitroaniline 
• 124-41-4 sodium methylate 
• 104222-34-6 2-nitro-4-fluoro-5-chloroaniline 
• 1662-21-1 N-(3,4-difluoro-2-nitrophenyl)acetamide 
• 458-11-7 3,4-difluoroacetanilide 
• 67-56-1 methanol 

Downstream Products

• 125163-15-7 4-Fluoro-5-methoxy-1,2-phenylenediamine 

Relevant articles and documents

NOVEL NUCLEOSIDE PHOSPHORAMIDATE COMPOUND AND USE THEREOF

The present invention provides a novel nucleoside phosphoramidate compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof for the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection. The present invention also provides the pharmaceutical composition comprising a compound of the present invention, or a stereoisomer, salt, hydrate, solvate or crystal thereof and a use of the compound or the composition of the present invention in the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection. The compound of the present invention has a good anti-HCV effect.

HEPATITIS C VIRUS INHIBITORS

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Benzofurazan derivatives as antifungal agents against phytopathogenic fungi

A series of benzofurazan derivatives were prepared and evaluated for their biological activities against four important phytopathogenic fungi, namely, Rhizoctonia solani, Sclerotinia sclerotiorum, Fusarium graminearum and Phytophthora capsici, using the mycelium growth inhibition method. The structures of these compounds were characterized by1H NMR,13C NMR, and HRMS. N-(3-chloro-4-fluorophenyl)-7-nitrobenzo[c][1,2,5] oxadiazol-4-amine (A3) displayed the maximum antifungal activity against R. solani (IC50= 1.91 μg/mL), which is close to that of the positive control Carbendazim (IC50= 1.42 μg/mL). For other benzofurazan derivatives with nitro group at R4position (A series), 9 out of 30 compounds exhibited high antifungal effect against strain R. solani, with IC50values less than 5 μg/mL. Most of the derivatives with substituents at R2and R3positions (B series) displayed moderate growth inhibition against S. sclerotiorum (IC504position and another conjugated aromatic ring at the R1position of the phenyl ring displayed high antifungal capability against strain R. solani. Compounds with substituents at R2and R3position had moderate efficacy against strain S. sclerotiorum.

Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa

Type II bacterial topoisomerases are well validated targets for antimicrobial chemotherapy. Novel bacterial type II topoisomerase inhibitors (NBTIs) of these targets are of interest for the development of new antibacterial agents that are not impacted by

Chemo-enzymatic synthesis and biological evaluation of 5,6-disubstituted benzimidazole ribo- and 2′-deoxyribonucleosides

A number of new 5,6-disubstituted benzimidazoles have been prepared and their substrate properties for recombinant E. coli purine nucleoside phosphorylase (PNP; the product of the deoD gene) in the transglycosylation reaction were investigated. The heterocyclic bases showed good substrate activity for PNP and the ribo- and 2-deoxyribonucleosides were synthesized. The predominant (OMe and OEt) or exclusive (Oi-Pr, morpholino, and N-methylpiperazino) formation of the 5-substituted 6-fluoro-1-(β-d- ribofuranosyl)benzimidazoles was observed. The formation of the regioisomeric 6- methoxy-, 6-ethoxy-, or 6-isopropoxy-substituted 1-(2-deoxy-β-d- ribofuranosyl)-5-fluorobenzimidazoles was observed in the trans-2- deoxyribosylation reaction of the corresponding bases. The predominant or exclusive formation of the regioisomeric N1-nucleosides with bulky 5-substituents of 6-fluorobenzimidazole points to a large hydrophobic pocket in the E. coli PNP active site that can accommodate these groups. The biological activity of the synthesized nucleosides was studied and revealed no inhibitory activity against a broad variety of DNA and RNA viruses. The compounds also lacked significant cytotoxicity. Georg Thieme Verlag Stuttgart New York.

PYRROLO[1,2-A]QUINOXALIN-5-(4H)-YL)SULFONYLS AND CARBONYLS AND THEIR USE AS ESTROGENIC AGENTS

This invention provides estrogen receptor modulators having the structure: wherein R1 to R7, R9 and R10 X, Y, and Z are as defined in the specification; or a pharmaceutically acceptable salt thereof.